ATTENDEES:

Representatives from research, industry, ethics, law, government, economic development, finance, insurance, foundations, societies, patient advocates and media all attend the Summit. It is an event that unites the global stem cell science and regenerative medicine communities, fostering insight, collaborations, commerce and an overall more favorable environment to accelerate progress.

ATTENDANCE BY TITLE

Quotes:

"The World Stem Cell Summit is a meeting of the stem cell minds, bringing Policy, science, industry, advocates and clinicians together in a unique and powerful forum. The Summit is of great value to researchers by providing a context for stem cell science that is not found at other meetings. By uniting the key stakeholder groups, the Summit grounds research direction with an understanding of the strategies that will be most beneficial for developing stem cell-based therapeutics.”

Sally Temple, Ph.D., Scientific Director
Neural Stem Cell Institute

“The World Stem Cell Summit is an extraordinarily important meeting of scientific researchers striving to convert the leading edge of stem cell research into therapies to reduce human suffering. The Summit’s presence in Pasadena highlights California’s leadership role in financing and building a global infrastructure for the development of innovative stem cell therapies; California has partnered with ten nations to bring the best of the world’s stem cell research together in world-class teams to drive the development of therapies."

Bob Klein, JD, MBA, Former Chairman of the Governing Board
California Institute for Regenerative Medicine

“As CIRM places a priority on developing therapies and finding cures, we welcome the 2011 World Stem Cell Summit’s focus on translational regenerative medicine. By working with the regenerative medicine business and investment community, who will be joining us in Pasadena, we can forge collaborations with California researchers and companies to accelerate effective therapies.”

Alan Trounson, Ph.D., President
California Institute for Regenerative Medicine

“We are pleased to welcome the Summit to the Los Angeles area, where stem cell research is flourishing at so many world class local institutions. City of Hope has a long history of advancing stem cell research and successfully applying those advances to save lives. More recently we have expanded our efforts and are able to serve as a national resource for other institutions developing and manufacturing stem cell-based therapies through our on-site, state-of-the-art GMP facilities. The summit will be a tremendous opportunity to exchange knowledge and ideas as well as form new collaborations from across town to around the world.”

Richard Jove, Ph.D., Director
Beckman Research Institute of City of Hope

“Here at Cedars Sinai we have made a robust commitment to advance regenerative medicine – from disease modeling to the discovery of effective cellular treatments. The Regenerative Medicine Institute unites both basic scientists and physician scientists across multiple medical specialties to translate findings from the research bench directly to the bedside. Having previously co-organized the World Stem Cell Summit in Wisconsin, I am very pleased to be involved once again in this exciting meeting.”

Clive Svendsen, Ph.D., Director
Cedars-Sinai Regenerative Medicine Institute

“We are extremely pleased that the organizers chose Pasadena to host the World Stem Cell Summit. The diverse program presents a comprehensive view of the stem cell world and the Caltech community looks forward to presenting advances in the development of important new technologies based on stem cell science and developmental biology.”

Paul Patterson, Ph.D., Professor of Biological Sciences
California Institute of Technology

“The Summit was particularly valuable to attendees, because of the networking opportunities and interdisciplinary exchanges of information. It gave a unique opportunity for representative from a variety of fields to communicate and collaborate. Policy experts learned about researcher’s needs. Advocates learn about policy and legislation. It also brought ethical issues to the table, which is critical if we’re going to resolve them and keep the research moving forward.”

Stephen Rose, Ph.D., Chief Research Officer
Foundation Fighting Blindness

“The World Stem Cell Summit is that unique opportunity that brings together patients, researchers, regulators and industry.  It is a great forum to discuss and understand the needs and challenges that the industry faces in bringing these medicines to market.  This has become a key meeting for us as we develop new technologies to enable stem cell research and development.”

Robert Shaw, Commercial Director Stem Cell Initiative
EMD Millipore Corp

"The World Stem Cell Summit is not only a must attend event on the latest advances in stem cell sciences but it is also an awe-inspiring, thought provoking event. Not only does the Summit provide cutting- edge scientific research but brings in the policymakers who will be the voice in government and the patients who will directly benefit from both the research and the government’s full support. It is one of the few events which touch all of us with the promise of hope, dedication, joy, sadness, courage, marvel and inspiration."

Nicholas Zachariades, Ph.D., Partner
Duane Morris, LLP

"I had a GREAT and UNIQUE experience at the 2010 Summit. First of all, because I think I´ve never attended such a live, diversified and stimulating meeting, with all kinds of players acting together towards the same goal of finding ways to cure or at least ameliorate degenerative diseases using stem cells, Tissue Engineering, Nanotechnology, Biotech, Ethics, Regulatory Guidelines, etc – in a true convergence. I have been talking about this Summit to everybody around – people from my lab, Heads of Departments, Heads of Brazilian research financing agencies, colleagues, friends and even my family members – I´m sure you´ll have many more attendees from Brazil next year!"

Mari Sogayar, Ph.D., Professor Chemistry Institute
University of São Paulo & Head of NUCEL (Cell and Molecular Therapy Center)